Hemiballism …

Virgilio Gerald H Evidente MD

Movement Disorders

Updated 06.19.2024
Released 02.09.1994
Expires For CME 06.19.2027

Hemiballism

Author: Virgilio Gerald H Evidente MD

See Contributor Disclosures

Editor: Robert Fekete MD

Hemiballism

In This Article

Quick Link

Introduction

Overview

Hemiballism is often a challenging movement disorder to manage, especially in severe cases. Outlined herein are some of the salient points that may help the clinician understand better the history, clinical spectrum, causes, pathophysiology, differential diagnoses, diagnostic workup, prognosis, and latest medical and surgical treatment options for hemiballism. A clinical vignette is also provided to illustrate a classic case of hemiballism.

Key points

	• Hemiballism refers to flinging movements of the upper and lower limbs on one side of the body.
	• Onset of hemiballism is usually acute and is most commonly due to ischemic stroke, hemorrhage, autoimmune disorders, medications, metabolic abnormalities (most commonly hyperglycemia), neoplasms, or infections.
	• Treatment is usually symptomatic unless a reversible cause can be identified and corrected (eg, hyperglycemia, infections, drugs, or metabolic abnormalities).
	• Drug therapy usually involves the use of neuroleptics or antiepileptic agents.
	• Medically refractory hemiballismus may be amenable to deep brain stimulation surgery.

Historical note and terminology

"Ballism,” (meaning "to throw" in Greek) refers to violent, irregular flinging limb movements. It constitutes part of the spectrum of chorea (meaning “to dance”) and is a result of proximal muscle contraction. There are several types of ballism, depending on the distribution of movements. The most common form is “hemiballism,” which involves flinging movements of the upper and lower extremities on one side of the body. Ballism confined to one extremity is referred to as “monoballism.” The term “paraballism” describes ballistic movements in both lower limbs, whereas “biballism” or “bilateral ballism” refers to movements in both sides of the body.

Clinicopathologic and experimental studies in Rhesus monkeys linked lesions of the subthalamic nucleus with contralateral hemiballism. However, hemiballism can also result from lesions of the thalamus, neostriatum, or cerebral cortex. Hemiballism/hemichorea has also been observed in patients with Parkinson disease who have undergone subthalamotomy or subthalamic deep brain stimulation (68). However, the ballism or chorea in these patients is usually short-lived and improves with a reduction of levodopa dosage. Thus, it is believed that normal individuals (those with a physiologically normal subthalamic nucleus) are prone to ballism with subthalamic nucleus lesioning, whereas patients with Parkinson disease (with an abnormal hyperactive subthalamic nucleus) are not.

Clinical manifestations

Presentation and course

Typically, hemiballism is of acute onset, but it may evolve over several days to weeks. The patient may be awakened by an abrupt onset of violent flinging movements of the proximal parts of an arm or leg on one side of the body.

Hemiballism due to stroke

This woman presented with a 2-month history of left hemiballism following an acute infarction in the right subthalamic nucleus. (Contributed by Dr. Joseph Jankovic.)
Hemiballism due to stroke, treated with tetrabenazine

This elderly woman developed right hemiballism following left subthalamic nucleus infarction and markedly improved with tetrabenazine, a dopamine-depleting drug. (Contributed by Dr. Joseph Jankovic.)

The movements can cause injury of the involved limbs and exhaustion. There may be involvement of the same side of the face with facial and tongue movements. Distally, choreic or athetotic movements of the fingers may be apparent. The movements are said to disappear during sleep, but hemiballism has been noted to persist during lighter stages of sleep.

The involuntary movements may improve with action, but, more frequently, they are worsened by attempts to move.

Bilateral ballism is uncommon and may be associated with dysarthria, dysphagia, and rarely, mutism.

Prognosis and complications

The prognosis depends on the underlying cause. In general, the prognosis of hemiballism due to vascular causes is favorable. If due to other causes, the prognosis depends on the underlying condition. Malignancy and AIDS, for instance, are associated with a poorer outcome. If due to correctible causes like hyperglycemia, parathyroid abnormalities, or certain drugs, the hemiballism is especially responsive to therapy. It is unclear whether the site of the lesion influences the prognosis. Lang reported two patients with hemiballism of long duration in which the lesions were outside the subthalamic nucleus (the striatum in particular) and were associated with an ominous prognosis (65). However, others have suggested that lesions outside of the subthalamic nucleus may be associated with a better chance of recovery (52).

In some patients, hemiballism may evolve into a hemidystonia. In others, it transforms into hemichorea before a complete resolution. Complications include exhaustion, bronchopneumonia, and physical or mechanical injuries to the involved limbs.

Clinical vignette

An 82-year-old hypertensive woman was diagnosed with nonketotic hyperglycemia and was started on an oral hypoglycemic agent. A month later, she developed involuntary, continuous, jerky movements of the right leg that gradually worsened over 3 to 4 days. The movements were partially suppressible for a few seconds and disappeared during sleep. They gradually worsened to the point of causing excoriations and bruising of the right leg and impairment of walking. The patient denied past intake of neuroleptics and any family history of movement disorder.

On examination 11 days after onset of the movements, severe, continuous hemiballism/hemichorea was seen in the right leg. The rest of the neurologic examination was unremarkable. Extensive serologic tests (including blood sugar, electrolytes, liver function tests, thyroid-stimulating hormone, parathyroid hormone, anticardiolipin antibodies, antinuclear antibodies, rapid plasma reagin, blood smear, complete blood count, and erythrocyte sedimentation rate) were normal. Cerebrospinal fluid (CSF) analysis was normal. Brain magnetic resonance imaging (MRI) showed symmetric, increased T1 and T2 signal in the basal ganglia bilaterally, small lacunes in the right and left thalami, and increased T2 signal in the periventricular white matter and subcortical white matter bilaterally. MRI of the cervical and thoracic spine showed normal spinal cord signal.

The patient was treated unsuccessfully with maximum tolerated doses of trihexyphenidyl (6 mg/day), clonazepam (1.5 mg/day), and olanzapine (7.5 mg/day). She was then tried on perphenazine (up to 6 mg/day), with only partial improvement of the leg movements. She was finally placed on risperidone, initially at 1 mg twice daily, then 1 mg three times daily 3 days later. She experienced complete resolution of her hemiballismus/hemichorea within 2 days of receiving 3 mg/day of risperidone. Her walking also normalized.

Biological basis

Etiology and pathogenesis

Hemiballism may be due to various etiologies.

Stroke is the most common cause, particularly ischemic infarction affecting the subthalamic nucleus, thalamus, caudate, putamen, centrum semiovale, corona radiata, or cerebral cortex (particularly the frontal lobe or parieto-occipital region) (21; 12; 49; 63; 103). Sometimes transient hemiballism may precede paralysis due to a subcortical stroke (42). Recurrent hemichorea associated with amaurosis fugax has been described due to transient ischemic attacks (69). Acute hemichorea has also been reported from transient ischemic attacks related to atrial flutter (50). Recurrent nocturnal hemiballism has also been described as a sequela of striatocapsular stroke (02). Ischemia involving either the anterior circulation (eg, carotid stenosis) or posterior circulation may have been reported to cause hemiballism, possibly because the subthalamic nucleus is supplied by both the anterior and posterior circulations by way of the anterior and posterior choroidal arteries, respectively. Hemichorea associated with extracranial carotid artery stenosis and thalamic and putaminal hypoperfusion on functional imaging has been described to reverse after carotid revascularization (87). Rarely, hemiballism may result from a disconnection syndrome of the parietal cortex from the basal ganglia due to stroke (92). One case of hemichorea was described from an ipsilateral frontal cortical infarction (110). Pediatric Moyamoya disease has also been reported to cause hemichoreic movements (58). RNF213-related vasculopathy was reported to cause hemichorea in an elderly woman with contralateral internal carotid stenosis with no acute stroke or lesions on MRI (51).

Hemorrhage, particularly involving the striatum, may also lead to hemiballism. A case of hemichorea secondary to contralateral pontine hemorrhage has also been reported (66). Hemorrhage may be due to hypertension, trauma (with or without subdural hematomas), vascular anomalies (like arteriovenous malformations and venous angiomas), or disseminated intravascular coagulation.

Neoplasms involving the basal ganglia, subthalamic nucleus, pallidosubthalamic pathways, or pituitary gland may also produce hemiballism, including brain metastasis, gliomas, meningiomas, ependymal cysts, and cavernous angiomas, among others (15; 35; 59). Hemichorea may also result from paraneoplastic syndromes due to pulmonary or renal cell carcinoma, or lymphoma (107). Paraneoplastic hemichorea has been described secondary to anti-CV2 antibodies associated with diffuse large B-cell lymphoma or LGI1 antibodies associated with renal cell carcinoma (23; 80).

An elderly patient with polycythemia vera presented with acute-onset hemichorea and frontal lobe syndrome, with brain imaging showing no vascular pathology in the basal ganglia or frontal region (43).

Brain infections may also lead to hemiballism, including tuberculous meningitis, tuberculoma (83), acquired immune deficiency syndrome (AIDS) (105), toxoplasmosis (29), cysticercosis, and Creutzfeldt-Jacob disease (72). In a review by Amod and colleagues of movement disorders related to HIV, generalized chorea was most frequently noted in HIV encephalopathy, whereas hemichorea was primarily seen in HIV patients with cranial toxoplasmosis (05). Cerebral toxoplasmosis leading to hemichorea-hemiballismus has also been described in a non-HIV immunocompromised adult patient who received allogenic hematopoietic stem cells from a related donor (90). Two pediatric cases of varicella-induced vasculopathy leading to acute hemichorea have been reported, with cranial MRI showing vasculitis and ischemic lesions in the basal ganglia (25). Two cases of acute and reversible hemichorea-hemiballism were described after COVID-19 vaccination with the AstraZeneca vaccine (AZD1222), which improved after a short course of corticosteroids (71). Based on the steroid-responsiveness of the two cases and normal brain scans, an inflammatory mechanism was proposed. Left-sided hemichorea-hemiballismus was described in a 90-year-old male after receiving his second dose of the Pfizer-BioNTech COVID-19 vaccine, with [18F]-fluorodeoxyglucose-positron emission tomography (FDG-PET) showing right putaminal hyperactivity (11). His hemichorea-hemiballism improved after 5 days of intravenous corticosteroids. Two adolescents developed hemichorea after receiving BBBIBP-CorV (Sinopharm), an inactivated virus COVID-19 vaccine (95). A review of literature by Rosca and colleagues revealed eight patients who developed hemichorea/hemiballism after COVID-19 vaccination, with three fourths of cases having onset within 2 weeks of vaccination; 87.5% had hemiballism, whereas 37.5% had hemichorea (91). It is theorized that the hemichorea/hemiballism after vaccination can be autoimmune related; in particular, focal immune-related endotheliopathy induced by the spike protein coupled with a genetic predisposition may be responsible for the movement disorder after COVID-19 vaccination. Alternatively, other mechanisms can be in play including vaccine-induced hyperglycemia or stroke. Chorea can also be an acute complication of COVID-19 encephalitis (07). In the same review done by Rosca and colleagues, they found 14 cases of chorea after COVID-19 infection, with onset anywhere from 1 to 3 days or up to 3 months after infection (91). They theorize that the chorea can be due to an autoimmune response to the infection, direct infection-related injury to the basal ganglia, or infection-related complication (ie, acute disseminated encephalomyelitis, cerebral venous sinus thrombosis, or hyperglycemia).

Autoimmune disorders, like systemic lupus erythematosus, antiphospholipid syndrome, multiple sclerosis, or Sydenham chorea, may produce hemichorea/hemiballism (15). Nonketotic hyperglycemic crisis in type 2 diabetes mellitus has also been reported to present with persistent chorea/ballism and is theorized to have an ischemic or autoimmune basis as well (01; 98). Hemichorea-hemiballism has been reported to be the initial presentation of type 2 diabetes (89). Hemichorea-hemiballism from type 2 diabetes may be worsened by episodes of hypoglycemia (93). Reports of chorea/ballism from ketotic hyperglycemia from type 1 diabetes mellitus are rarer and tend to be seen in younger individuals (09). Cerebrospinal fluid in nonketotic hyperglycemia-associated hemichorea/hemiballism may show an elevation of protein concentration, increased IgG, elevated IgG index or 24-hour intrathecal IgG synthesis rate, thus, suggesting that inflammation within the central nervous system may participate in its pathogenesis (109). A 14-year-old girl with a history of Sydenham chorea presented with a recurrence of chorea after contracting COVID-19 (117). Anti-IgLON5 disease, an autoimmune encephalopathy with sleep disturbance, bulbar dysfunction, dysautonomia, and cognitive impairment, can present with isolated hemichorea (48).

Various drugs can cause hemiballism. Neuroleptic medications, used for psychiatric reasons or for nausea, may lead to tardive dyskinesias, which can be choreic or ballistic in nature. Olanzapine was reported to precipitate hemichorea-hemiballism in a 44-year-old male with uncontrolled type 2 diabetes mellitus (34). Oral contraceptives have a tendency to bring out latent hemichorea/hemiballism, especially in individuals with a history of Sydenham chorea (18). In some, hemichorea may develop from oral contraceptive use despite the absence of predisposing factors like lupus or antiphospholipid antibodies (106). Phenytoin intoxication can lead to bilateral ballism. Bilateral ballism was noted in an epileptic patient receiving 200 mg/day of lamotrigine; the ballism completely resolved on discontinuation of the drug (113). One case of gabapentin-induced hemichorea was also reported, with cerebral hypoperfusion observed on functional imaging in the contralateral basal ganglion (62). Chorea was noted in bilateral upper limbs and face in a woman with brain metastasis with seizures who was treated with IV levetiracetam (114). One case of sertraline-induced hemichorea was discovered 1 week after administration of sertraline for depression. All involuntary movements gradually stopped on discontinuation of sertraline (44). Levofloxacin was found to induce hemichorea-hemiballism in a patient with a previous thalamic infarction (10). Memantine was discovered to cause chorea and dystonia in an elderly patient with Alzheimer disease who had an accidental overdose of memantine when switching from immediate release to sustained release memantine. All symptoms stopped once memantine was discontinued (14).

Overuse of the antitussive cloperastine was reported to induce hemichorea (22). Reversible hemichorea has also been reported to occur with valproate use (101). Two pediatric cases of ifosfamide-induced hemiballism with encephalopathy were described that improved with the administration of methylene blue and thiamine (04).

Parkinsonian syndromes, particularly Parkinson disease, multiple system atrophy (104), or striatal degeneration (16), may be associated with hemiballism. In patients with Parkinson disease, this is usually seen in advanced disease and chronic levodopa treatment. Patients with Parkinson disease who have undergone stereotactic thalamotomy (27) or subthalamotomy may also develop iatrogenic hemiballism (19). Subthalamic deep brain stimulation in Parkinson disease may result in transient hemiballism (68). Chorea was discovered to be a side effect in a patient who underwent deep brain stimulation for treatment of obsessive-compulsive disorder. Electrodes initially implanted in the anteromedial portion of the STN alleviated compulsive behaviors, but caused large choreatic movements of the limbs. Motor side effects were reduced on transfer of electrodes to the ventral capsule/ventral striatum region, while still retaining therapeutic effect (77).

Hemiballism and dysarthria due to and relief of parkinsonism by subthalamic nucleus stimulation in Parkinson disease

This man with advanced Parkinson disease has characteristic extrapyramidal signs during the true “off” state (at least 12 hours after last dose of levodopa). The signs include a coarse tremor, which involves the left lower extremi...

Stimulation-induced hemichorea has also been described in a patient with essential tremor who underwent ventral intermedius deep brain stimulation but with the lead being situated too ventrally (100).

Children with static encephalopathy may develop recurrent episodes of generalized, violent ballism that are provoked by relatively minor infectious illnesses or surgical procedures (13). Hemichorea has also been described in Wilson disease (55) and in children with nutritional vitamin D deficiency (38). Hemichorea has been described in a patient with tuberous sclerosis complex and unilateral basal ganglia atrophy (37).

Other causes of hemichorea and hemiballism include idiopathic hypoparathyroidism (31), hyperthyroidism (74), ventriculoperitoneal shunting (03), and migrainous aura (112). Hypoglycemia-induced acute-onset hemichorea was described in an elderly type 2 diabetic patient with Fahr syndrome and basal ganglia calcifications who developed hypoglycemia following insulin overtreatment (86). A Chinese individual presented with hemichorea-hemiballism associated with contralateral basal ganglia calcifications due to Fahr disease with heterozygous mutation in the SLC20A2 gene (118).

Classically, ballism has been associated with an ischemic or hemorrhagic lesion of the contralateral subthalamic nucleus. However, neuroimaging studies have shown that lesions of areas outside of the subthalamic nucleus (eg, caudate or putamen) are found more often than previously thought (108). Furthermore, ipsilateral putaminal lesions have been noted in hyperglycemia-associated hemichorea-hemiballism (40). There seems to be some somatotopic organization within the subthalamic nucleus with posterior subthalamic nucleus lesions resulting in monoballism of the contralateral lower limb (81). Ballism from pallidal lesions usually involves the external segment. Clinicopathological studies by Carpenter and colleagues (17) showed that hemiballism results if at least 20% of the subthalamic nucleus is involved and is abolished with lesioning of the internal segment of the globus pallidus. Hemiballism is believed to be due to a lack of tonic inhibition of the lateral globus pallidus by the putamen, leading to a greater inhibition of the subthalamic nucleus and lack of excitation of the medial globus pallidus; this ultimately results in disinhibition of the thalamus and the motor cortex. This may not hold true for every case of ballism and does not explain why a lesion of the presumably underexcited or inactive medial globus pallidus would abolish hemiballism in experimental situations. Also, this model does not explain the rare occurrence of hemiballism with lesions of the lateral pallidal segment.

Neuropathological examination of a patient who suffered from hemiballism from nonketotic hyperglycemia showed presence of activated microglia on immunohistochemistry in the subthalamic nucleus contralateral to the hemiballism (70).

The neurochemistry of hemiballism is also unclear. It is possible that it is associated with dopaminergic hyperactivity, as suggested by responsiveness to dopamine-blocking agents (36) and elevation of cerebrospinal fluid homovanillic acid levels in patients with hemiballism. Injections of GABA antagonists into the subthalamic nucleus or in different regions of the lenticular nucleus may produce hemiballism, suggesting the role of GABAergic neurons (24). Using transcranial magnetic stimulation, patients with hemichorea-hemiballism related to uncontrolled diabetes were determined to have increased long-interval intracortical inhibition during muscle activation but not at rest, as well as increased silent period duration, thus, suggesting increased GABA-B receptor-mediated inhibitory activity in the contralateral motor cortex (67). The efficacy of the selective serotonin reuptake inhibitors in controlling hemiballism implies that serotoninergic neurons may also be involved (82).

Diagnostic workup

In the setting of acute hemiballism, a brain imaging study (either CT or MRI with contrast) should be performed to look for subthalamic nucleus lesions (or other basal ganglionic or thalamic lesions). In the absence of hemorrhage, areas of abnormal contrast enhancement may suggest tumor, infection, inflammation, or active demyelination. In hemiballism-hemichorea associated with nonketotic hyperglycemia, putaminal hyperintensity is noted on T1 without diffusion restriction on diffusion weight imaging (DWI); putaminal hypointensity can also be seen without phase shift on susceptibility weight imaging (SWI). These findings are compatible with either pathological mineralization or petechial microhemorrhages or protein denaturation (08). T1 hyperintensity may be from the protein hydration layer inside the cytoplasm of swollen gemistocytes appearing after acute cerebral injury; these astrocytes express metallothionein with zinc, which is thought to be the cause of asymmetric hypointensity of the posterior putamen on SWI (20). Putaminal changes on brain imaging may also be noted before the onset of clinical symptoms (78). A case of hypoglycemic encephalopathy presenting with hemichorea-hemiballism was associated with contralateral frontoparietal cortical-subcortical T2 and T2-FLAIR-hyperintense lesions with no basal ganglia abnormalities noted (88). When a brain MRI fails to show the responsible lesion in the setting of acute hemichorea, evaluation of cerebral blood flow using single-photon emission computed tomography (SPECT) may detect hypoperfusion in the subthalamic area or thalamus (96). Hyperglycemic hemichorea has also been associated with marked hypometabolism on 18F-fluorodeoxyglusose (FDG) positron emission tomography (PET) in the contralateral basal ganglia (61). A case of hyperglycemic hemichorea was described as not only being associated with increased T1 signal intensity in bilateral lenticular nuclei but also with dopamine transporter (DaT) imaging abnormalities consisting of absent uptake in the putamina bilaterally and moderately diminished uptake in the right caudate (30). Given the absence of parkinsonism, it was theorized that the swollen astrocytes noted in hyperglycemic chorea-ballism may be the structural basis for the falsely positive DAT scan.

Routine blood chemistry should include fasting and postprandial blood sugar determinations and measurement of serum calcium and phosphorus. In appropriate patients, antiepileptic drug levels should be obtained. In patients with hemiballism and a history of intravenous drug abuse, multiple sexual partners, homosexuality, or immunocompromised state (eg, malignancy), one should look for evidence of AIDS and AIDS-related infections or neoplastic processes. In a child with ballism, one should look for evidence of previous streptococcal infection and active carditis (to rule out Sydenham chorea).

Serum antinuclear antibodies, anticardiolipin antibodies, and lupus anticoagulants should be tested in young individuals (to rule out antiphospholipid syndrome), particularly in women with a history of recurrent spontaneous abortions, recurrent deep venous thrombosis, or other thrombotic events. Antibasal ganglia antibodies may also be detected in some patients with choreic disorders, especially those with a history of Sydenham chorea or oral contraceptive use, thus, suggesting an immunological basis for the abnormal movements (75).

Electroencephalography (EEG) is usually normal, though periodic lateralized epileptiform discharges (PLEDS) was reported in a case of hemiballism-hemichorea related to hyperglycemia (111).

Management

Proper management hinges on the correct identification and treatment of the underlying cause. Hemiballism due to destructive lesions is treated symptomatically.

The most effective drugs are those that block the postsynaptic dopamine D2 receptors. Traditional neuroleptics, like haloperidol or perphenazine (18), have been the most common drugs used to treat hemiballism. Not uncommonly, withdrawal of such drugs results in the reemergence of hemiballism, suggesting that the movements are only being suppressed symptomatically. Atypical antipsychotic agents, like clozapine (102) or risperidone (36), olanzapine (84), or quetiapine (unpublished observation) may be as effective as traditional neuroleptics but may be associated with less incidence of extrapyramidal side effects. Tardive dyskinesia may also develop from chronic risperidone usage, particularly at doses higher than 6 mg/day. Dopamine depletors, like tetrabenazine and reserpine, have been used with some success (85). Two novel selective vesicular monoamine transporter 2 (VMAT2) inhibitors, valbenazine and deutetrabenazine, have longer half-lives and better side effect profile than tetrabenazine, including less somnolence, parkinsonism, depression, and akathisia (54). Valbenazine was approved and released in 2017 for tardive dyskinesias (57). Unlike tetrabenazine, which is metabolized to α-isomers and β-isomers (the latter has minimal dopamine D2 receptor antagonism properties), valbenazine only has the (+)-α-isomer. Deutetrabenazine, a deuterated form of tetrabenazine, was also released in the first half of 2017 for Huntington chorea and approved for release in the second half of 2017 for tardive dyskinesias (06).

Antiepileptic agents may be useful in some patients with hemiballism. Sodium valproate has had inconsistent benefits in patients with hemiballism (97) and may rarely cause choreiform movements in patients with severe epilepsy and brain damage (64). Gabapentin was noted to be effective in controlling hemichorea/hemiballism due to stroke (60). Topiramate was reported to be effective in the management of refractory hemichorea/hemiballism, either of vascular or metabolic etiology (33). A case of vascular hemichorea/hemiballismus was also reported to respond significantly to topiramate (45). Levetiracetam has also been noted to be efficacious in alleviating hemiballismus related to subthalamic hemorrhage (73).

Progabide, a GABAergic agent (46) and dimethylaminoethanol, which increases acetylcholine, have been reported to benefit patients with hemiballism (53).

Sertraline, a selective serotonin reuptake inhibitor, has also been reported to alleviate hemiballism (82).

A case involving a patient with diabetic chorea demonstrated a successful reduction of motor symptoms through a combination of gabapentin and levodopa (116).

Repetitive transcranial magnetic stimulation of the motor cortex was successfully used to alleviate poststroke hemichorea, though the benefit was reported to last only 24 hours after each session of stimulation (28).

Acupuncture has been described to be beneficial in a Chinese patient with nonketotic hyperglycemic hemichorea-hemiballism (115).

Patients with hemiballism unresponsive to oral medications may respond to botulinum toxin injections (32). Such therapy, however, results in limb weakness, and the effect only lasts 3 months on average.

Intrathecal baclofen was noted to be effective in controlling severe lower limb ballism in a patient with posttraumatic hemiballismus and dystonia that was unresponsive to various oral medications, botulinum toxin injections, and phenol injections (41).

Patients who are unresponsive to medications or are sensitive to their side effects may be candidates for stereotactic lesioning procedures like thalamotomy or pallidotomy (99) or deep brain stimulation of the thalamus or globus pallidus (76). Microelectrode recordings of a patient with diabetic hemichorea-hemiballism showed abnormalities in the globus pallidus interna consisting of irregular firing with pauses (47). This may explain why pallidotomy or pallidal stimulation may help hemichorea-hemiballism, as those procedures lead to blocking of the irregular choreogenic neuronal firing in the globus pallidus interna.

A case of persistent and medically refractory hemichorea/hemiballism from diabetes was also reported to have a long-term response to contralateral thalamic deep brain stimulation with the ventral oralis anterior and posterior nuclei as targets (79).

Low-frequency repetitive transcranial magnetic stimulation (rTMS) has been used successfully with rehabilitation therapy to alleviate persistent hemichorea/hemiballism after nonketotic hyperglycemia (56).

Media

References

01: Ahlskog JE, Nishino H, Evidente VG, et al. Persistent chorea triggered by hyperglycemic crisis in diabetics. Mov Disord 2001;16:890-8. PMID 11746619
02: Ahn BJ, Kwon KY. Recurrent episodes of nocturnal hemiballism: a post-stroke movement disorder. Parkinsonism Relat Disord 2017;42:102-4. PMID 28625596
03: Alakandy LM, Iyer RV, Golash A. Hemichorea, an unusual complication of ventriculoperitoneal shunt. J Clin Neurosci 2008;15(5):599-601. PMID 18328713
04: Ames B, Lewis LD, Chaffee S, Kim J, Morse R. Ifosfamide-induced encephalopathy and movement disorder. Ped Blood Cancer 2010;54:624-6. PMID 19953647
05: Amod F, Holla VV, Ojha R, Pandey S, Yadav R, Pal PK. A review of movement disorders in persons living with HIV. Parkinsonism Relat Disord 2023;114:105774. PMID 37532621
06: Anderson KE, Stamler D, Davis MD, et al. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Psychiatry 2017;4(8):595-604. PMID 28668671
07: Ashrafi F, Salari M, Hojjati Pour F. Chorea as a post-COVID-19 complication. Mov Disord Clin Pract 2022;9(8):1144–8. PMID 36249280
08: Atay M, Yetis H, Kurtcan S, Aralasmak A, Alkan A. Susceptibility weighted imaging features of nonketotic hyperglycemia: unusual cause of hemichorea-hemiballismus. J Neuroimaging 2015;25(2):319-24. PMID 24612187
09: Awasthi D, Tiwari AK, Upadhyaya A, Singh B, Tomar GS. Ketotic hyperglycemia with movement disorder. J Emerg Trauma Shock 2012;5(1):90-1. PMID 22416165
10: Bacchin R, Macchione F, Cardellini D, et al. Levofloxacin-induced hemichorea-hemiballism in a patient with previous thalamic infarction. Neurol Sci 2018;39(8):1483-5. PMID 29511961
11: Batot C, Chea M, Zeidan S, et al. Clinical and radiological follow-up of a Pfizer-BioNTech COVID-19 vaccine-induced hemichorea-hemiballismus. Tremor Other Hyperkinet Mov (N Y) 2022;12:16. PMID 35646423
12: Bejot Y, Caillier M, Osseby GV, et al. Involuntary masturbation and hemiballismus after bilateral anterior cerebral artery infarction. Clin Neurol Neurosurg 2008;110(2):190-3. PMID 17961914
13: Beran-Koehn MA, Zupanc ML, Patterson MC, Olk DG, Ahlskog JE. Violent recurrent ballism associated with infections in two children with static encephalopathy. Mov Disord 2000;15:570-4. PMID 10830425
14: Borges LG, Bonakdarpour B. Memantine-induced chorea and dystonia. Pract Neurol 2017;17(2):133-4. PMID 27927775
15: Burnett L, Jankovic J. Chorea and ballism. Curr Opin Neurol Neurosurg 1992;5:308-13. PMID 1535815
16: Calopa M, Ferrer I, Villanueva P, Obeso JA. Bilateral asymmetric degeneration of the striatum as a cause of senile hemiballism [Spanish]. Neurologia 1997;12:92-5. PMID 9147460
17: Carpenter MB, Whittier JR, Mettler FA. Analysis of choreoid hyperkinesia in the Rhesus monkey. J Comp Neurol 1950;92:293-332. PMID 15422067
18: Caviness JN. Huntington’s disease and other choreas. In: Ahlskog JE, Adler CH, editors. Parkinson's Disease and Movement Disorders: Diagnosis and Treatment Guidelines For the Practicing Physician. Totowa, New Jersey: The Humana Press, 2000:321-38.
19: Chen CC, Lee ST, Wu T, Chen CJ, Huang CC, Lu CS. Hemiballism after subthalamotomy in patients with Parkinson’s disease: report of 2 cases. Mov Disord 2002;17:1367-71. PMID 12465086
20: Cherian A, Thomas B, Baheti NN, Chemmanam T, Kesavadas C. Concepts and controversies in nonketotic hyperglycemia-induced hemichorea: further evidence from susceptibility-weighted MR imaging. J Magn Reson Imaging 2009;29:699-703. PMID 19243044
21: Chung SJ, Im JH, Lee MC, Kim JS. Hemichorea after stroke: clinical-radiological correlation. J Neurol 2004;251(6):725-9. PMID 15311349
22: Civardi C, Collini A, Enrico E, Maggio M, Geda C. Induced hemichorea by cloperastine overuse. Neurol Sci 2020;41(7):1959-60. PMID 31997120
23: Colletta K, Kartha N, Chawla J. Paraneoplastic puzzle: an unusual case of hemichorea, renal cell carcinoma, and LGI1 antibody. Mov Disord Clin Pract 2018;5(3):337-8. PMID 30363438
24: Crossman AR, Mitchell IJ, Sambrook MA, Jackson A. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. Brain 1988;111:1211-33. PMID 3179691
25: Davico C, Canavese C, Tocchet A, Brusa C, Vitiello B. Acute hemichorea can be the only clinical manifestation of post-Varicella vasculopathy: two pediatric clinical cases. Front Neurol 2018;9:164. PMID 29615962
26: Dewey RB, Jankovic J. Hemiballism-hemichorea: clinical and pharmacologic findings in 21 patients. Arch Neurol 1989;46:862-7. PMID 2757526
27: Dierssen G, Bergman LL, Gioino GG. Hemiballism following surgery for Parkinson's disease. Arch Neurol 1961;5:63-73. PMID 13886278
28: Di Lazzaro V, Dileone M, Pilato F, et al. Repetitive transcranial magnetic stimulation of the motor cortex for hemichorea. J Neurol Neurosurg Psych 2006;77:1095-7. PMID 16914763
29: Dimal NPM, Santos NJC, Reyes NGD, Astejada MN, Jamora RDG. Hemichorea-hemiballismus as a presentation of cerebritis from intracranial toxoplasmosis and tuberculosis. Tremor Other Hyperkinet Mov 2021;11:2. PMID 33552670
30: Doher N, Gupta HV. DaT scan "abnormality" in hyperglycemic-hemichorea. Tremor Other Hyperkinet Mov 2019;15;9. PMID 31824748
31: Dragasevic N, Petkovic-Medved B, Svetel M, Filipovic SR, Kostic VS. Paroxysmal hemiballism and idiopathic hypoparathyroidism. J Neurol 1997;244(6):389-90. PMID 9249626
32: Dressler D, Wittstock M, Benecke R. Treatment of persistent hemiballism with botulinum toxin type A. Mov Disord 2000;15:1281-2. PMID 11104226
33: Driver-Dunckley E, Evidente VG. Hemichorea-hemiballismus may respond to topiramate. Clin Neuropharm 2005;28(3):142-4. PMID 15965315
34: Elsherif A, Jun J. PSUN245 Non-ketotic hyperglycemic hemichorea-hemiballismus precipitated by antipsychotics. J Endocr Soc 2022;6(Suppl 1):A389-90.
35: Erer S, Yilmazlar S, Zarifoglu M, Guclu M. A case report on pituitary macroadenoma presented as hemichorea hemiballism syndrome. Neurol Sci 2008;29(4):289-90. PMID 18810608
36: Evidente VG, Gwinn-Hardy K, Caviness JN, Adler CH. Risperidone is effective in severe hemichorea/hemiballismus. Mov Disord 1999;14:377-9. PMID 10091643
37: Ferlazzo E, Gasparini S, Gambardella A, et al. Unilateral basal ganglia atrophy in a patient with tuberous sclerosis complex and hemichorea. Mov Disord 2012;27(3):458-60. PMID 22173950
38: Fernandez R, Ambika A, Dure, LS. Nutritional vitamin D deficiency presenting as hemichorea. J Child Neurol 2007;22:74-6. PMID 17608310
39: Finsterer J, Rettensteiner J. Immediate resolution of acute, choreatic hyperkinesias following intravenous fentanyl. Niger J Clin Pract 2017;20(1):119-22. PMID 27958259
40: Fong SL, Tan AH, Lau KF, Ramli N, Lim SY. Hyperglycemia-associated hemichorea-hemiballismus with predominant ipsilateral putaminal abnormality on neuroimaging. J Mov Disord 2019;12(3):187-9. PMID 31390855
41: Francisco GE. Successful treatment of posttraumatic hemiballismus with intrathecal baclofen therapy. Am J Phys Med Rehab 2006;85:779-82. PMID 16924190
42: Fukui T, Hasegawa Y, Seriama S, Takeuchi T, Sugita K, Tsukagoshi H. Hemiballism-hemichorea induced by subcortical ischemia. Can J Neurol Sci 1993;20:324-8. PMID 8313249
43: Garcia-Cabo C, Fernandez-Dominguez J, Mateos V. Sudden hemichorea and frontal lobe syndrome: a rare presentation of unbalanced polycythaemia vera. BMJ Case Rep 2018;2018. PMID 29764825
44: Gatto EM, Aldinio V, Parisi V, et al. Sertraline-induced hemichorea. Tremor Other Hyperkinet Mov (N Y) 2017;7:518. PMID 29276648
45: Gatto EM, Uribe Roca C, Raina G, Gorja M, Folgar S, Micheli FE. Vascular hemichorea/hemiballismus and topiramate. Mov Disord 2004;19(7):836-8. PMID 15254947
46: Gonce M, Schoenen J, Charlier M, Delwaide P. Successful treatment of hemiballismus with progabide, a new GABA-mimetic agent. J Neurol 1983;229:121-4. PMID 6190997
47: Goto T, Hashimoto T, Hirayama S, Kitazawa K. Pallidal neuronal activity in diabetic hemichorea-hemiballism. Mov Disord 2010:25:1295-7. PMID 20629129
48: Grossauer A, Hussl A, Mahlknecht P, et al. Anti-IgLON5 disease with isolated hemichorea: a case report and review of the literature. Mov Disord Clin Pract 2023;10(1):115-9. PMID 36698996
49: Hao M, Qin X, Gao H. A case of hemichorea-hemiballism induced by acute infarction of bilateral corona radiata and cortex. Cell Biochem Biophys 2015;73(1):171-4. PMID 25707502
50: Hebant B, Guyant-Marechal L, Maltête D, Lefaucheur R. Acute hemichorea revealing atrial flutter. J Postgrad Med 2018;65(1):50-1. PMID 30588926
51: Hosoki S, Yoshimoto T, Ihara M. A case of hemichorea in RNF213-related vasculopathy. BMC Neurol 2021;21(1):32. PMID 33482763
52: Hyland HH, Forman DM. Prognosis in hemiballismus. Neurology (Minneapolis) 1957;7:381-91. PMID 13430900
53: Jameson HD, Blacker HM, Fuchs ME. Hemiballismus-hemichorea treated with dimethylaminoethanol. Dis Nerv Syst 1977;33:931-2. PMID 913228
54: Jankovic J. Dopamine depleters in the treatment of hyperkinetic movement disorders. Expert Opin Pharmacother 2016;17(18):2461-70. PMID 27819145
55: Juan CJ, Chen CY, Liu YJ, et al. Acute putaminal necrosis and white matter demyelination in a child with subnormal copper metabolism in Wilson disease: MR imaging and spectroscopic findings. Neuroradiology 2005;47(6):401-5. PMID 15909172
56: Kaseda Y, Yamawaki T, Ikeda J, et al. Amelioration of persistent, non-ketotic hyperglycemia-induced hemichorea by repetitive transcranial magnetic stimulation. Case Rep Neurol 2013;5(1):68-73. PMID 23626568
57: Kim ES. Valbenazine: first global approval. Drugs 2017;77(10):1123-9. PMID 28578484
58: Kim YO, Kim TS, Woo YJ, Kim CJ, Oh CK. Moyamoya disease-induced hemichorea corrected by indirect bypass surgery. Pediatr Internat 2006;48:504-6. PMID 16970793
59: Kongsakorn N, Maroongroge P. A case of hemichorea caused by cerebral cavernous angioma. J Med Assoc Thai 2015;98 Suppl 9:S165-9. PMID 26817227
60: Kothare SV, Pollack P, Kulberg AG, Ravin PD. Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus. Pediatr Neurol 2000;22(1):68-71. PMID 10669210
61: Kumar Vadi S, Mehta S, Kumar R, Tandyala N, Singh H, Mittal BR. Severe contralateral striatal hypometabolism in a case of diabetic nonketotic hyperglycemic hemichorea on 18F-FDG PET/CT brain. Clin Nucl Med 2020;45(2):e117-9. PMID 31714279
62: Lai MH, Wang TY, Chang CC, Tsai KC, Chang ST. Hemichorea associated with gabapentin therapy with hypoperfusion in contralateral basal ganglion. J Clin Pharm Ther 2008;33(1):83-6. PMID 18211622
63: Lancellotti G, Sagot C, Forst A, Greffard S, Bertrand A, Verny M. An unusual case of hemiballism-hemichorea associated with nonketotic hyperglycemia in association with a centrum semiovale stroke. J Am Geriatr Soc 2015;63(8):1720-1. PMID 26289707
64: Lancman ME, Asconape JJ, Penry K. Choreiform movements associated with the use of valproate. Arch Neurol 1994;51:702-4. PMID 8018044
65: Lang AE. Persistent hemiballism with lesions outside the subthalamic nucleus. Can J Neurol Sci 1985;12:125-8. PMID 3926289
66: Larrosa D, Ramon C, Santamarta E, Zeidan N, Pascual J. Hemichorea secondary to contralateral pontine haemorrhage. Parkinsonism Relat Disord 2013;19(2):271-2. PMID 22795480
67: Li JY, Chen R. Increased intracortical inhibition in hyperglycemic hemichorea-hemiballism. Mov Disord 2015;30(2):198-205. PMID 24919927
68: Limousin P, Pollock P, Hoffman D, Benazzouz A, Perret JE, Benabid AL. Abnormal involuntary movements induced by subthalamic stimulation in parkinsonian patients. Mov Disord 1996;11:231-5. PMID 8723137
69: Littleton ET, Glover N, Tiwari A. Recurrent amaurosis fugax and hemichorea: limb-shaking TIA. Pract Neurol 2015;15(3):218-20. PMID 25617405
70: Maeda K, Katayama Y, Sugimoto T, et al. Activated microglia in the subthalamic nucleus in hyperglycaemic hemiballism: a case report. J Neurol Neurosurg Psychiatry 2010;81:1175-7. PMID 20547634
71: Matar E, Manser D, Spies JM, Worthington JM, Parratt KL. Acute hemichorea-hemiballismus following COVID-19 (AZD1222) vaccination. Mov Disord 2021;36(12):2714-5. PMID 34581453
72: Maltete D, Guyant-Marechal L, Mihout M, Hannequin D. Movement disorders and Creutzfeldt-Jakob disease: a review. Parkinsonism Relat Disord 2006;12:65-71. PMID 16364674
73: Marchione P, Vento C, Marianetti M, Romeo T, Amabile GA, Giacomini P. Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam. Eur J Neurol 2009;16:e112-3. PMID 19453693
74: Miao J, Liu R, Li J, Du Y, Zhang W, Li Z. Meige’s syndrome and hemichorea associated with hyperthyroidism. J Neurol Sci 2010;288:175-7. PMID 19883923
75: Miranda M, Cardoso F, Giovannoni G, Church A. Oral contraceptive induced chorea: another condition associated with anti-basal ganglia antibodies. J Neurol Neurosurg Psychiatry 2004;75(2):327-8. PMID 14742621
76: Montgomery EB Jr. Deep brain stimulation for hyperkinetic disorders. Neurosurg Focus 2004;17(1):E1. PMID 15264770
77: Mulders AEP, Leentjens AFG, Schruers K, Duits A, Ackermans L, Temel Y. Choreatic side effects of deep brain stimulation of the anteromedial subthalamic nucleus for treatment-resistant obsessive-compulsive disorder. World Neurosurg 2017;104:1048..e9-1048.e13. PMID 28532905
78: Nakajima N, Udea M, Nagayama H, Katayama Y. Putaminal changes before the onset of clinical symptoms in diabetic hemichorea-hemiballism. Intern Med 2014;53(5):489-91. PMID 24583441
79: Nakano N, Uchiyama T, Okuda T, Kitano M, Taneda M. Successful long-term deep brain stimulation for hemichorea-hemiballism in a patient with diabetes. Case report. J Neurosurg 2005;102(6):1137-41. PMID 16028776
80: Nevison S, Rizek P. Anti-CV2-associated paraneoplastic hemichorea secondary to diffuse large B-cell lymphoma. Can J Neurol Sci 2019;46(4):480-1. PMID 31057136
81: Ohinshi J. A case of monoballism in unilateral lower extremity--somatotopic relation in subthalamic nucleus [Article in Japanese]. Rinsho Shinkeigaku 1992;32:506-10. PMID 1458728
82: Okun MS, Riestra AR, Nadeau SE. Treatment of ballism and pseudobulbar affect with sertraline. Arch Neurol 2001;58:1682-4. PMID 11594930
83: Ozer F, Meral H, Aydemir T, Ozturk O. Hemiballism-hemichorea in presentation of cranial tuberculoma. Mov Disord 2006;21:1293-4. PMID 16700030
84: Paleacu D, Anca M, Giladi N. Olanzapine in Huntington’s chorea. Acta Neurol Scand 2002;105:441-4. PMID 12027832
85: Paleacu D, Giladi N, Moore O, Stern A, Honigman S, Badarny S. Tetrabenazine treatment in movement disorders. Clin Neuropharmacol 2004;27(5):230-4. PMID 15602104
86: Paraskevas GP, Vlachos GS, Vassilopoulou S, Anagnostou E, Spengos K, Zis V. Hypoglycemia-induced hemichorea in a patient with Fahr's syndrome. Neurol Sci 2012;33(6):1397-9. PMID 22526769
87: Parees I, Pujadas F, Hernandez-Vara J, et al. Reversible hemichorea associated with extracranial carotid artery stenosis. J Neurol Sci 2011;300:185-6. PMID 20888600
88: Pasini F, Karantzoulis A, Fanella G, et al. Hypoglycemic encephalopathy manifesting with cortical hemichorea-hemiballismus syndrome: a case report. Case Rep Neurol 2023;15(1):24-30. PMID 36762000
89: Ray S, Howlader S, Chakraborty S, Chakraborty PP, Ghosh S. Hemichorea-hemiballism as the first presentation of type 2 diabetes. Clin Diabetes 2015;33(2):87-9. PMID 25897191
90: Rocha-Cadman X, Revilla AR, Cadman K, Root JC. Hemichorea-hemiballismus associated with a case of cerebral toxoplasmosis in a hematopoietic stem cell transplant recipient. Palliat Support Care 2024;22(3):623-5. PMID 38314508
91: Rosca EC, Bilavu R, Cornea A, Simu M. Chorea following SARS-CoV-2 infection and vaccination: a systematic review of reported cases. Int J Infect Dis 2023;134:256-60. PMID 37423421
92: Rossetti AO, Ghika JA, Vingerhoets F, Novy J, Bogousslavsky J. Neurogenic pain and abnormal movements contralateral to an anterior parietal artery stroke. Arch Neurol 2003;60(7):1004-6. PMID 12873859
93: Rupp J, Gillespie A. A case of diabetic hemichorea hemiballismus exacerbated by hypoglycemia. AACE Clin Case Rep 2021;7(5):327-9. PMID 34522775
94: Safan AS, Sharma O, Almasri M, D'Souza AI, Suliman O. Is diabetic striatopathy the culprit of seizures in a patient with ketotic hyperglycemia-induced hemichorea-hemiballismus? BMC Neurol 2022;22(1):133. PMID 35395738
95: Salari M, Etemadifar M. Two cousins with acute hemichorea after BBIBP-CorV (Sinopharm) COVID-19 vaccine. Mov Disord 2022;37(5):1101-3. PMID 35262222
96: Sehara Y, Otsuka H, Kaneko N, Ando Y, Sawada M. Significance of N-isopropyl-[123I] p-iodoamphetamine single-photon emission computed tomography in detection of responsible hypoperfusion in hemichorea. J Clin Neurosci 2019;70:260-3. PMID 31447357
97: Sethi KD, Patel BP. Inconsistent response to divalproex sodium in hemichorea/hemiballism. Neurology 1990;40:1630-1. PMID 2215961
98: Sitburana O, Ondo WG. Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus. Mov Disord 2006;21:2023-5. PMID 16986158
99: Slavin KV, Baumann TK, Burchiel KJ. Treatment of hemiballismus with stereotactic pallidotomy. Case report and review of literature. Neurosurg Focus 2004;17(1):E7. PMID 15264776
100: Spears CC, Almeida L, Okun MS, Deeb W. An unusual case of essential tremor deep brain stimulation: where is the lead? Tremor Other Hyperkinet Mov (N Y) 2019;9:617. PMID 30867977
101: Srinivasan S, Lok AW. Valproate-induced reversible hemichorea. Mov Disord 2010;10:1511-2. PMID 20629154
102: Stojanovic M, Sternic N, Kostic VS. Clozapine in hemiballismus: report of two cases. Clin Neuropharmacol 1997;20:171-4. PMID 9099471
103: Strauss S, Rafie D, Nimma A, Romero R, Hanna PA. Pure cortical stroke causing hemichorea-hemiballismus. J Stroke Cerebrovasc Dis 2019:104287. PMID 31351828
104: Testa D, Grisoli M, Monza D, Girotti F. Hemiballism in a patient with probable multiple system atrophy. Funct Neurol 1997;12:45-9. PMID 9127123
105: Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W. Movement disorders and AIDS: a review. Parkinsonism Relat Disord 2004;10(6):323-4. PMID 15261874
106: Vela L, Sfakianakis GN, Heros D, Koller W, Singer C. Chorea and contraceptives: case report with pet study and review of the literature. Mov Disord 2004;19(3):349-52. PMID 15022195
107: Vernino S, Tuite P, Adler CH, et al. Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol 2002;51:625-30. PMID 12112110
108: Vidakovic A, Dragasevic N, Kostic VS. Hemiballism: report of 25 cases. J Neurol Neurosurg Psychiatry 1994:57:945-9. PMID 7914529
109: Wang JH, Wu T, Deng BQ, Zhang YW, Zhang P, Wang ZK. Hemichorea-hemiballismus associated with nonketotic hyperglycemia: a possible role of inflammation. J Neurol Sci 2009;284:198-202. PMID 19428031
110: Wei J, Zhang Y. Hemichorea in a patient with ipsilateral cortical infarction: a case report. BMC Neurol 2021;21(1):420. PMID 34715809
111: Wu MN, Ruge D, Tsai CL, Hsu CY, Lai CL, Liou LM. Periodic lateralized epileptiform discharges associated with irreversible hyperglycemic hemichorea-hemiballism. Clin EEG Neurosci 2014;45(4)315-7. PMID 24590873
112: Yamada K, Harada M, Inoue N, Yoshida S, Morioka M, Kuratsu J. Concurrent hemichorea and migrainous aura – a perfusion study on the basal ganglia using xenon-computed tomography. Mov Disord 2008;23(3):425-9. PMID 18067174
113: Yetimalar Y, Seckin M, Secil Y, Basoglu M. Lamotrigine-induced bilateral ballism. Mov Disord 2007;22:1832-3. PMID 17534939
114: Yim SH, Choi YH, Heo K, Cho KH. A case of dyskinesia after levetiracetam administration. BMC Neurol 2019;19(1):292. PMID 31739779
115: Ying C, Jingqing S, Tianli L, et al. Effect of acupuncture treatment on nonketotic hyperglycemic hemichorea-hemiballismus: a case report. J Tradit Chin Med 2023;43(4):829-33. PMID 37454270
116: Yokoi K, Kazuta T, Torii R, Endo T, Araki A, Terao S. Effectiveness of levodopa treatment for diabetic chorea with reduced striatal accumulation in dopamine transporter SPECT: a case report. Rinsho Shinkeigaku 2017;57(10):591-4. PMID 28954970
117: Yuksel MF, Yıldırım M, Bektaş Ö, Şahin S, Teber S. A sydenham chorea attack associated with COVID-19 infection. Brain Behav Immun Health 2021;13:100222. PMID 33615279
118: Zhu SH, Peng JJ, Li KF, Peng JC, Li J. Non-ketotic hyperglycaemic hemichorea-hemiballismus with Fahr's disease in a Chinese family: a case report. Int J Neurosci 2022:1-5. PMID 35510430

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Virgilio Gerald H Evidente MD

Dr. Evidente of the Movement Disorders Center of Arizona received honorariums and/or research support from Acadia, Aeon Biopharma Inc, Amneal, CND, Ipsen, Metronic, Neurocrine, Revance, and Teva as investigator, consultant, and/or speaker.
See Profile

Editor

Robert Fekete MD

Dr. Fekete of New York Medical College received consultation fees from Acadia Pharmaceutical, Acorda, Adamas/Supernus Pharmaceuticals, Amneal/Impax, Kyowa Kirin, Lundbeck Inc., Neurocrine Inc., and Teva Pharmaceutical, Inc.
See Profile

Former Authors

Kapil D Sethi MD

Patient Profile

Age range of presentation: 19 to 65+ years
Sex preponderance: male=female
Heredity: none
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Other chorea: G25.5
ICD-11: Hemiballism: 8A01.22

Other specified hemichorea or hemiballismus: 8A01.2Y

Hemichorea or hemiballismus, unspecified: 8A01.2Z

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Hemiballism

Associated Disorders

AIDS with cerebral toxoplasmosis
Cerebral arteriovenous malformation
Cerebral hemorrhage
Cerebral infarction
Cerebral ischemia
- Cerebral venous angioma
- COVID-19
- Cysticercosis
- Ependymal cyst
- Head trauma
- Hemichorea
- Hyperglycemia
- Metastatic brain tumor
- Multiple sclerosis
- Primary cystic gliomas
- Toxoplasmosis
- Tuberculous meningitis
- Tuberous sclerosis

Differential Diagnosis

partial seizures
myoclonus
other involuntary movements
partial motor seizures
negative myoclonus (asterixis)
- hemichorea

Also Relevant

AIDS and HIV: neurologic manifestations and complications
Botulinum toxin treatment of neurologic disorders
Cerebral palsy
Cerebral toxoplasmosis
Chorea
- Motor control of movement disorders
- Movement disorders associated with infection
- Posttraumatic movement disorders
- Rating scales of movement disorders

Clinical Categories

Movement Disorders

Web References

Clinical Trials

NIH: Chorea

Hemiballism …

Hemiballism

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Dementia in Parkinson disease

ALS-like disorders of the Western Pacific

Sleep and cerebral degenerative disorders

Progressive supranuclear palsy: cognitive and behavioral changes

Imaging of movement disorders

Movement disorders in chromosomal aneuploidies

Fragile X-associated tremor/ataxia syndrome

Functional (psychogenic) movement disorders

Hemiballism

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Special considerations

Pregnancy

Anesthesia

Media

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Dementia in Parkinson disease

ALS-like disorders of the Western Pacific

Sleep and cerebral degenerative disorders

Progressive supranuclear palsy: cognitive and behavioral changes

Imaging of movement disorders

Movement disorders in chromosomal aneuploidies

Fragile X-associated tremor/ataxia syndrome

Functional (psychogenic) movement disorders

This is an article preview.
Start a Free Account
to access the full version.